CONNECT WITH US
HealthTech

HealthTech

Steatotic liver disease risk scores compared for predicting cirrhosis

Medical Xpress logo

Published on

Add as a preferred source on Google
Steatotic liver disease risk scores compared for predicting cirrhosis

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

For patients with steatotic liver disease (SLD), the steatosis-associated fibrosis estimator (SAFE) score demonstrated the greatest net benefit for predicting cirrhosis, according to a study published online Sept. 21 in JAMA Internal Medicine.

Catherine Mezzacappa, M.D., Ph.D., M.P.H., from the Yale School of Medicine in New Haven, Connecticut, and colleagues compared the clinical utility of SLD risk scores for predicting cirrhosis and hepatocellular carcinoma (HCC) in patients with noncirrhotic SLD. The cohort study used data from adults with imaging-confirmed SLD in the national U.S. Veterans Affairs health system. Nine clinical risk scores were evaluated for their ability to predict cirrhosis or HCC within 10 years.

The analysis included 853,131 patients, of whom 3.96% developed cirrhosis and 0.35% developed HCC within 10 years. The fibrosis-4 index (FIB-4), the aspartate aminotransferase-to-platelet ratio and SAFE scores showed the greatest discrimination of cirrhosis risk; the SAFE, Tate and FIB-4 scores showed the greatest discrimination of HCC risk.

The SAFE score had the greatest net benefit for predicting cirrhosis. A score of 29.5 corresponded to a 10-year cirrhosis risk of 2.5% and a net benefit of 0.019 (1.9 additional individuals who develop cirrhosis per 100 classified as at risk). The SAFE score had a net benefit of 0.0016 at a 0.25% 10-year risk for HCC.

"This comparative validation study highlights the importance of assessing test performance at relevant thresholds for clinical practice," the authors write.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.